Today, Lilly/BI announced first-ever news in diabetes: a major clinical trial on Jardiance, an SGLT-2 inhibitor pill for type 2 diabetes, has been proven to improve heart safety in patients at high risk for heart problems.
Jardiance Becomes First Ever TII Diabetes Drug to Improve Heart Health